Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc down on Thursday (RX)

Automated Summaries - The Globe and Mail - Thu Apr 18, 4:02PM CDT

In today's trading, shares of Biosyent Inc opened at $8.52 and closed at $8.45. prices ranged from a low of $8.45 to a high of $8.53.

The price decreased -1.17% from the previous day's close of $8.55.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21708.44, the S&P 500 closed sp_500_percentage_change% at 5022.21, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37753.31 and the Nasdaq Composite closed nasdaq_percentage_change% at 15683.37.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

Trading volume was 3,772 on 13 total trades, while having an average volume of 2,780 in the last five days.

The TSX-V overall saw 2,663 price advancers against 2,504 declines and 146 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have raised 10.89% in the last 52 weeks, while this year, they have dipped -8.35%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $99.26 million on a float of 11,610 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Biosyent Inc's average recommendation is "Moderate Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe